Medicines rebate agreement for calcium carbonate and colecalciferol

Summary

The tender concerns a framework agreement for medicines containing the active substance calcium carbonate + colecalciferol (ATC M05BB04). DAK-Gesundheit intends to conclude a non-exclusive rebate agreement with as many interested pharmaceutical companies as possible for the period 01/07/2026–30/06/2028, with an option to extend once by 12 months. The machine-readable notice did not include precise qualification, exclusion or compliance requirements; these must be checked in the tender documents.